Johnson & Johnson said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for ...

The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on ...

Fall season has arrived and with it, cooler temps and more dangers for your body. According to the CDC, during a six-month period last fall and winter infections caused over 800,000 hospitalizations!

There's still a lot of confusion around the best time to take a COVID test and where to get them. Here, experts share their ...

Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...

NV-387 Could be the Answer to the MPox Clade I Rising in the USA, Says Dr. Diwan ...

Get Q3 2025 Pfizer earnings call insights—guidance raised, major acquisitions, regulatory updates, and R&D highlights.

Moderna MRNA is set to report third-quarter 2025 earnings on Nov. 6, before the opening bell. The Zacks Consensus Estimate ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Shares plunge 36% after nine-year DMD drug trial misses endpoint. Q3 revenue beats but clinical failure dominates sentiment.

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.